Key SASP components—specifically IL-1β, IL-6, IL-16, ICAM-1, and ICAM-2—demonstrated a mechanistic role in exacerbating hepatic inflammation, thereby accelerating the onset and progression of pro-inflammatory cascades in experimental models of NAFLD. This evidence concerns the gene IL16 and metabolic dysfunction-associated steatotic liver disease.